InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Michael Cruse, Chief Operating Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 5 open-market SEC Form 4 transactions: 5 purchases worth $64K and 0 sales worth $0, reported from Aug 25, 21 to Sep 1, 22. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 22 | RPHMReneo Pharmaceuticals, Inc. | BUY | 7.5K | $3.39 | $25K |
| Aug 31, 22 | RPHMReneo Pharmaceuticals, Inc. | BUY | 3.2K | $3.21 | $10K |
| Aug 30, 22 | RPHMReneo Pharmaceuticals, Inc. | BUY | 1.8K | $3.19 | $6K |
| Aug 29, 22 | RPHMReneo Pharmaceuticals, Inc. | BUY | 1.1K | $3.24 | $4K |
| Aug 25, 21 | RPHMReneo Pharmaceuticals, Inc. | BUY | 2.5K | $7.45 | $19K |